These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34381546)

  • 1. Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018.
    Johnson BW; Demanou M; Fall G; Betoulle JL; Obiekea C; Basile AJ; Domingo C; Goodman C; Mossel E; Reusken C; Staples E; de Morais JFM; Neto Z; Paixão P; Denon YE; Glitho M; Mahinou J; Kagone T; Nakoune E; Gamougam K; Simbu EP; Ahuka S; Mombouli JV; Goma-Nkoua C; Adjogoua EV; Tayachew A; Beyene B; Sanneh B; Jarju ML; Mendy A; Amelor DK; Ofosu-Appiah L; Opare D; Antwi L; Adade R; Magassouba N; Gomes SF; Limbaso S; Lutomiah J; Gbelee B; Dogba J; Cisse I; Idde Z; Ihekweazu C; Mba N; Faye O; Faye O; Sall AA; Koroma Z; Juma MA; Maror JA; Eldigail M; Elduma AH; Elageb R; Badziklou K; Komla KA; Kayiwa J; Lutwama JJ; Hampton L; Mulders MN
    Pan Afr Med J; 2021; 38():402. PubMed ID: 34381546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of RealStar Yellow Fever Virus RT-PCR kit 1.0 for potential use in the global yellow fever laboratory network.
    Basile AJ; Niedrig M; Lambert AJ; Meurant R; Brault AC; Domingo C; Goodman CH; Johnson BW; Mossel EC; Mulders MN; Velez JO; Hughes HR
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010770. PubMed ID: 36067233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical viability of the YF MAC-HD ELISA kit for use in yellow fever-endemic regions.
    Goodman CH; Demanou M; Mulders M; Mendez-Rico J; Basile AJ
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009417. PubMed ID: 34086676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of yellow fever on the developing world.
    Tomori O
    Adv Virus Res; 1999; 53():5-34. PubMed ID: 10582093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an ELISA kit (YF MAC-HD) to detect IgM to yellow fever virus.
    Basile AJ; Goodman C; Horiuchi K; Laven J; Panella AJ; Kosoy O; Lanciotti RS; Johnson BW
    J Virol Methods; 2015 Dec; 225():41-8. PubMed ID: 26342907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Adrien N; Hyde TB; Gacic-Dobo M; Hombach J; Krishnaswamy A; Lambach P
    Vaccine; 2019 Jul; 37(32):4511-4517. PubMed ID: 31266670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
    Hamlet A; Jean K; Yactayo S; Benzler J; Cibrelus L; Ferguson N; Garske T
    Vaccine; 2019 Mar; 37(11):1384-1388. PubMed ID: 30770224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever: a reemerging threat.
    Gardner CL; Ryman KD
    Clin Lab Med; 2010 Mar; 30(1):237-60. PubMed ID: 20513550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of yellow fever in Africa.
    Mutebi JP; Barrett AD
    Microbes Infect; 2002 Nov; 4(14):1459-68. PubMed ID: 12475636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow Fever Remains a Potential Threat to Public Health.
    Vasconcelos PF; Monath TP
    Vector Borne Zoonotic Dis; 2016 Aug; 16(8):566-7. PubMed ID: 27400066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
    Tomori O
    Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.